AGTC receives EMA ODD for achromatopsia: http://finance.yahoo.com/news/agtc-announces-orphan-drug-designation-110100476.html The ODD refers to AGTC’s program pertaining to mutations in the CNGA3 gene, but not to the program for mutations in the CNGB3 gene.